1. Obesity and overweight. World Health Organization (WHO); 2012. Fact Sheet No. 311. (Accessed February 7, 2014), available from :http://www.who.int/mediacentre/factsheets/fs311/en/
2. Debra A , Krummel. Medical nutrition therapy for cardiovascular disease. Krause, editor. Krause’s Food, Nutrition and Diet Therapy. 12th ed. Philadelphia, USA: Saunders; 2008. PP 833-64.
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
4. Davignon J, Ganz P . Role of Endothelial Dysfunction in Atherosclerosis. Circ J 2004; 109 (3): 27-32.
5. Mather KJ, Mirzamohammadi B, Lteif A, Steinberg HO, Baron AD. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002; 51:3517-23.
6. Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M. Is obesity associated with increased plasma lipid Peroxidation and oxidative stress in women? ARYA Atheroscler 2006; 2 (4): 189-94.
7. Vincent HK,Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 2006; 30: 400-18.
8. Karatas F, Karatepe M, Baysar A. Determination of free malondialdehyde in human serum by high-performance liquid chromatography. Anal Biochem 2002; 311: 76-9.
9. Adly AM . Oxidative stress and disease: An updated review. Res J Immunol 2010; 3 (2): 129-45.
10. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist Circumference as the Best Predictor of Noninsulin Dependent Diabetes Mellitus (NIDDM) Compared to Body Mass Index, Waist/hip Ratio and Other Anthropometric Measurements in Mexican Americans- A 7-Year Prospective Study. Obes Res 1997; 5(1): 16-23.
11. Waist circumference and waist–hip ratio: report of a WHO expert consultation. World health organization, 2008. Geneva. (Accessed on February 8, 2014). Available from http: // www.who.org
12. Amanullah M, Zaman GS, Rahman J, Rahman SS . Lipid peroxidation and the levels of antioxidant enzymes in hypertension. Free Radicals and Antioxidants 2012; 2 (2): 12-8. 80
13. Gutteridge J, Halliwell B . The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990; 15: 129-35.
14. Caballero AE . Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease. Obes Res 2003; 11: 1278-89.
15. Maeda S, Jesmin S, Iemitsu M, Otsuki T, Matsuo T, Ohkawara K. Weight Loss Reduces Plasma Endothelin-1 Concentration in Obese Men. EBM 2006; 231: 1044-7.
16. Lilyasari O, Kosasih A, Liastuti L, Librantoro, Gunawan I R, Idham I, et al. Increased Circulating Endothelin-1 in Obesity-related hypertension, but not in Obesity or Hypertension Alone. Circ J 2007; 116 (2): 341-4.
17. Cerri E. Obesity and endothelial dysfunction: mechanisms, method development and interventions. PhD thesis. University of Birmingham Institutional Research Archive. eTheses Repository; 2009. [Online] [Accessed on 14th, Oct, 2012]. Available from: http://etheses.bham.ac.uk/393/
18. Selvakumar C, Maheshwari U, Suganthi, Archana . Oxidant-Antioxidant disturbance in men classified as obese according to the preliminary WHO guidelines for Asians. JSPB 2012; 8 (1): 172-81.
19. Lachieitner M, Koch T, Harold M, Dzien A, Hoppiahler F. Tumor necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J Intern Med 2000; 248: 67-76. 20. El-Mesallamy H, Suwailem S, Hamdy N. Evaluation of C-Reactive Protein, Endothelin-1, Adhesion Molecule(s), and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus Patients. Mediators Inflamm; 2007.(Accessed on 28th, Aug, 2012), Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820618/